Davita Inc. last reported quarterly results on Oct 29, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $3.6 billion (+4.6% year over year) and diluted EPS of $3.40. It usually reports 29–35 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 1, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Monday. Based on last year's release for the same quarter on Feb 2, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 29–35 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 29, 2026
29 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
3,578
+4.6%
|
223
+48.3%
|
3.40
+66.7%
|
|
Aug 4, 2026
35 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
3,554
+5.2%
|
265
+33.1%
|
4.02
+55.8%
|
|
May 5, 2026
35 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
3,416
+6.0%
|
198
+21.2%
|
2.87
+43.5%
|
|
Feb 2, 2026
33 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
3,620
+9.9%
|
234
-9.7%
|
3.29
+6.3%
|
|
Oct 29, 2025
29 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
3,420
+4.8%
|
150
-30.0%
|
2.04
-18.4%
|
|
Aug 5, 2025
36 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
3,380
+6.1%
|
199
-10.5%
|
2.58
+3.2%
|
|
May 12, 2025
42 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
3,224
+5.0%
|
163
-32.0%
|
2.00
-24.5%
|
|
Feb 13, 2025
44 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
3,295
+4.7%
|
259
+72.1%
|
3.09
+90.4%
|
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- DVA (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Denver, CO
- SEC filer status
- Large accelerated filer
- SEC CIK
- 927066
- Former names
- DAVITA HEALTHCARE PARTNERS INC. (until Aug 12, 2016); DAVITA INC (until Nov 2, 2012); TOTAL RENAL CARE HOLDINGS INC (until Jan 28, 2000)
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
- Marpai, Inc. MRAI
All 15 Services-Misc Health & Allied Services, NEC companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.